I 
119TH CONGRESS 
1ST SESSION H. R. 3493 
To reduce prescription drug prices by aligning U.S. prices with international 
benchmarks. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 19, 2025 
Mr. KHANNA (for himself, Mrs. LUNA, Ms. KAPTUR, and Mr. BIGGS of Ari-
zona) introduced the following bill; which was referred to the Committee 
on Energy and Commerce, and in addition to the Committees on Ways 
and Means, and the Judiciary, for a period to be subsequently determined 
by the Speaker, in each case for consideration of such provisions as fall 
within the jurisdiction of the committee concerned 
A BILL 
To reduce prescription drug prices by aligning U.S. prices 
with international benchmarks. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Global Fairness in 
Drug Pricing Act’’. 
SEC. 2. DRUG PRICING. 
(a) MOST-FAVORED NATION PRICE TARGETS.—Not 
later than 30 days after the date of enactment of this Act, 
VerDate Sep 11 2014 
02:48 May 28, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3493.IH
H3493
kjohnson on DSK7ZCZBW3PROD with $$_JOB
the Secretary of Health and Human Services shall, in co-
ordination with the Administrator of the Centers for Medi-
care & Medicaid Services and other heads of relevant Fed-
eral agencies—propose a rulemaking plan to impose most- 
favored-nation price targets to pharmaceutical manufac-
turers to ensure that prices for pharmaceutical products 
paid by patients in the United States are comparable to 
the prices for such products paid by comparably developed 
countries. 
(b) IMPORTATION BY INDIVIDUALS.—The Secretary 
of Health and Human Services shall certify to Congress 
that importation under section 804(j) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 384(j)) will pose no 
risk to the health and safety of the public and will result 
in a significant reduction in the cost of prescription drugs 
to the American patients in the United States; and the 
Secretary of Health and Human Services shall take action 
under section 804(j)(2)(B) of such Act to describe cir-
cumstances under which waivers will be consistently grant-
ed to individuals to import prescription drugs, on a case- 
by-case basis, from developed countries with low-cost pre-
scription drugs. 
(c) ENFORCEMENT ACTIONS.—The Attorney General 
and the Chair of the Federal Trade Commission shall, to 
the extent consistent with law, undertake enforcement ac-
VerDate Sep 11 2014 
02:48 May 28, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3493.IH
H3493
kjohnson on DSK7ZCZBW3PROD with $$_JOB
tion against any anticompetitive practices by pharma-
ceutical manufacturers, including through enforcement of 
sections 1 and 2 of the Sherman Act (15 U.S.C. 1, 2) 
and section 5 of the Federal Trade Commission Act (15 
U.S.C. 45), as appropriate. 
(d) PROGRAMS ENABLING DIRECT-TO-CONSUMER 
PURCHASES.—To the extent permitted by law, the Sec-
retary of Health and Human Services shall facilitate di-
rect-to-consumer purchasing programs for pharmaceutical 
manufacturers that sell their pharmaceutical products to 
patients in the United States at the prices determined 
through the rulemaking under subsection (a). 
(e) STUDY OF UNREASONABLE OR DISCRIMINATORY 
BEHAVIORS
OF MANUFACTURERS.—The Secretary of 
Commerce and the United States Trade Representative 
shall conduct a study to determine whether any act, policy, 
or practice by pharmaceutical manufacturers constitutes 
unreasonable or discriminatory behavior that— 
(1) impairs national security; 
(2) forces patients in the United States to sub-
sidize global pharmaceutical research and develop-
ment; or 
(3) involves suppression of drug prices in for-
eign markets below fair market value. 
VerDate Sep 11 2014 
02:48 May 28, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3493.IH
H3493
kjohnson on DSK7ZCZBW3PROD with $$_JOB
The findings of such a study shall be submitted in a report 
to Congress not later than 180 days after the date of the 
enactment of this Act. 
Æ 
VerDate Sep 11 2014 
02:48 May 28, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H3493.IH
H3493
kjohnson on DSK7ZCZBW3PROD with $$_JOB